macrophage

Overview

Macrophages are mononuclear phagocytes with two distinct origins: circulating monocytes recruited into tissue, and embryonic and fetal progenitors that seed tissues before birth. The resident populations founded by the second route — microglia in the brain, Kupffer cells in the liver, alveolar macrophages in the lung — largely maintain themselves by local self-renewal rather than by monocyte replacement, which is why their behavior is set as much by tissue niche as by lineage. Macrophage identity is defined by a combination of markers such as CD68, CD64 and MERTK rather than by any single one; CD11b is shared with neutrophils and other myeloid cells, so it distinguishes myeloid from non-myeloid rather than identifying macrophages. Activation is conventionally described as a spectrum between M1 (pro-inflammatory) and M2 (anti-inflammatory, tissue-remodeling) states, a shorthand drawn from cultured cells that remains useful for orientation, though macrophages in tissue occupy stimulus-specific states that do not resolve cleanly onto that axis.

Their core functions are phagocytosis of pathogens and debris, clearance of apoptotic cells, antigen presentation to T-lymphocytes, and secretion of the cytokines and chemokines that recruit and instruct other cells. Clearance of dying cells is not merely disposal: it actively signals resolution, shifting the macrophage toward a reparative program and terminating inflammation. Through the same machinery macrophages handle iron and lipid — recycling iron from senescent erythrocytes, and taking up modified lipoproteins in the artery wall, where sustained uptake converts them into the foam cells of atherosclerotic plaque. They act as integrators within immune networks, exchanging signals with dendritic cell populations, T lymphocytes, and natural killer cell populations to shape both innate and adaptive responses.

That same plasticity makes them a therapeutic target from both directions. In chronic inflammatory disease such as rheumatoid arthritis and atherosclerosis, macrophages sustain pathology through oxidative stress and tissue damage, and the goal is to repolarize them toward resolution. In cancer, tumor-associated macrophages (TAMs) are among the most abundant cells of the tumor microenvironment, where they suppress T cell responses, promote angiogenesis, and support metastasis; reprogramming them toward an inflammatory, anti-tumor phenotype is an active immunotherapy strategy. Their appetite for particulate material cuts both ways in drug delivery: it clears nanoparticles from circulation before they reach their target, and it also makes the macrophage itself an addressable one.

Recent Publications Summary

Recent publications highlight macrophages as central, highly plastic cells in diverse disease settings, especially within the tumor microenvironment, where tumor-associated macrophages regulate angiogenesis, metastasis, immune evasion, and therapeutic resistance. A review of TAM-targeted nanomedicine emphasized that single-cell transcriptomics and spatial profiling have revealed substantial macrophage heterogeneity beyond the classic M1/M2 framework, motivating more refined strategies aimed at macrophage recruitment, depletion, reprogramming, and enhancement of phagocytosis, antigen presentation, and immune regulation 42370186Jun. In parallel, a spatial CRISPR screening platform linked gene perturbations to macrophage-related spatial phenotypes, showing that Icam1 loss in tumor cells can promote metastasis via immune suppression and macrophage polarization, while CD44 was implicated in spatial signaling through interaction with Spp1 on macrophages 42190664May.

Several studies focused on macrophage-directed nanomedicine and immunotherapy. In cancer, dual-targeting aptamer-drug hybrids delivering doxorubicin and the STING agonist diABZI were reported to remodel the immunosuppressive tumor microenvironment, promoting dendritic cell recruitment and activation and expanding IFN-responsive macrophages 41973478Apr. Another nanoplatform using ratio-tunable peptides against CD47 and PD-L1, combined with ultrasound-activated sonodynamic therapy, was designed to induce immunogenic cell death and enhance antitumor immunity, with downstream effects on immune-cell activation in the tumor setting 41979280Apr. A review of exosome-mediated crosstalk in lung cancer similarly described tumor-derived exosomes as drivers of macrophage polarization toward the tumor-supportive M2 phenotype, contributing to immune evasion and therapeutic resistance 41759799Feb. Hydatid cyst components were also described as immunomodulatory agents capable of activating macrophages alongside natural killer cells and T lymphocytes, with proposed antitumor effects in experimental models 41785598Mar.

Outside oncology, macrophages were linked to inflammatory and regenerative processes. In rheumatoid arthritis, inflammation-targeted nanoaggregates carrying triptolide and hyperoside were designed to selectively target M1 macrophages and promote M1-to-M2 repolarization while reducing reactive oxygen species and oxidative stress, with improved drug accumulation in inflamed joints in CIA mice 41795263Mar. In a murine model of sleep apnea induced by intermittent hypoxia, systemic depletion of CD11b+ cells improved metabolic function and insulin sensitivity, supporting a pathogenic role for monocytes/macrophages in adipose tissue inflammation and metabolic dysfunction 42041119Apr. In endometrial injury, time-series single-cell and spatial omics showed that macrophages rapidly infiltrate during the early inflammatory phase and are indispensable for regeneration, in part by promoting SFRP4+ stromal-cell reprogramming through tumor necrosis factor-α (TNF-α) 42234562Jun. A diabetic wound-healing study likewise found that exosome-loaded conductive hydrogel combined with electrical stimulation recruited macrophages and increased IL-10 to drive M2 polarization, thereby alleviating inflammation and accelerating repair 41576607Jan.

Macrophages were also examined in relation to biomaterial responses and atherosclerosis. In vaccine-induced granulomas, macrophages were implicated in the in vivo intracellular crystallization of aluminum oxyhydroxide adjuvant, with crystalline-like structures observed exclusively in adjuvanted tissues and interpreted as macrophage-associated crystalloid bodies 42062044Apr. In atherosclerosis, macrophages in plaques were described as key regulators of inflammation and plaque stability, and targeted delivery strategies were highlighted as a way to reduce systemic side effects while improving therapeutic precision 42333862Jun.

What Changes, What Holds

1. Macrophage heterogeneity now looks too broad for a simple M1/M2 model
NEW DIRECTION Single-cell and spatial profiling extend the baseline’s plasticity claim by showing that tumor-associated macrophages are not well captured by the classic binary framework, and that therapeutic strategies may need to target recruitment, depletion, reprogramming, and functional enhancement more selectively. The spatial CRISPR result also adds a mechanistic layer to tumor–macrophage crosstalk, but it is still early evidence that will need broader validation before it can redefine practice. 42370186Jun42190664May

2. Macrophage-directed cancer therapy is moving toward coordinated immune remodeling rather than macrophage targeting alone
REINFORCES These studies strengthen the baseline view that macrophages are major nanomedicine and immunotherapy targets in cancer, while showing that benefit may come from coupling macrophage modulation with dendritic-cell activation, immunogenic cell death, and checkpoint-related immune activation. The work does not overturn the established role of tumor-associated macrophages in immune evasion; it sharpens the therapeutic logic for reprogramming the tumor microenvironment. 41973478Apr41979280Apr

3. Macrophages remain central to inflammatory injury, but the new work broadens their role to regeneration and metabolic disease
NEW DIRECTION The rheumatoid arthritis and wound-healing findings fit the baseline’s anti-inflammatory repolarization framework, yet the sleep-apnea and endometrial-injury studies extend macrophage biology into systemic metabolic dysfunction and tissue regeneration, areas the overview did not explicitly cover. That makes macrophages look less like disease-specific effectors and more like context-dependent regulators of repair, inflammation, and metabolism, though the causal strength varies by model. 41795263Mar42041119Apr42234562Jun41576607Jan

4. Macrophage responses to adjuvants and atherosclerotic plaques are being refined, not reversed
REINFORCES The granuloma finding adds a more specific picture of how macrophages handle aluminum adjuvant material, but it does not conflict with their known phagocytic and homeostatic functions. Likewise, the atherosclerosis work supports the baseline’s view that macrophages drive plaque inflammation and are therapeutic targets. Together these studies mainly sharpen existing disease associations and delivery concepts rather than changing the underlying account. 42062044Apr42333862Jun

Overview update candidates: macrophage heterogeneity beyond the M1/M2 framework; macrophage roles in regeneration and metabolic dysfunction; macrophage involvement in adjuvant crystallization within granulomas.